{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T02:54:46Z","timestamp":1784170486671,"version":"3.55.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,4,18]],"date-time":"2024-04-18T00:00:00Z","timestamp":1713398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,18]],"date-time":"2024-04-18T00:00:00Z","timestamp":1713398400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Parasit."],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s11686-024-00845-8","type":"journal-article","created":{"date-parts":[[2024,4,18]],"date-time":"2024-04-18T10:19:23Z","timestamp":1713435563000},"page":"1201-1211","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["High Efficacy of Green Synthesized Silver Nanoparticles for Treatment of Toxoplasma Gondii Infection Through Their Immunomodulatory, Anti-Inflammatory, and Antioxidant Potency"],"prefix":"10.1007","volume":"69","author":[{"given":"Qais A.H.","family":"Majeed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sultan F.","family":"Alnomasy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah F.","family":"Shater","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4862-7668","authenticated-orcid":false,"given":"Abdullah D.","family":"Alanazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,18]]},"reference":[{"issue":"11","key":"845_CR1","doi-asserted-by":"publisher","first-page":"805","DOI":"10.3109\/00365548.2012.693197","volume":"44","author":"G Saadatnia","year":"2012","unstructured":"Saadatnia G, Golkar M (2012) A review on human toxoplasmosis. Scand J Infect Dis 44(11):805\u2013814. https:\/\/doi.org\/10.3109\/00365548.2012.693197","journal-title":"Scand J Infect Dis"},{"issue":"4","key":"845_CR2","first-page":"898","volume":"36","author":"A Molan","year":"2019","unstructured":"Molan A, Nosaka K, Hunter M, Wang W (2019) Global status of Toxoplasma gondii infection: systematic review and prevalence snapshots. Trop Biomed 36(4):898\u2013925 PMID 33597463","journal-title":"Trop Biomed"},{"key":"845_CR3","doi-asserted-by":"publisher","unstructured":"Martinez VO, de Mendon\u00e7a Lima FW, De Carvalho CF, Menezes-Filho JA (2018) Toxoplasma gondii infection and behavioral outcomes in humans: a systematic review. Parasitol Res.;117(10):3059-65. https:\/\/doi.org\/10.1007\/s00436-018-6040-2","DOI":"10.1007\/s00436-018-6040-2"},{"issue":"5","key":"845_CR4","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1891\/0730-0832.34.5.274","volume":"34","author":"MM Hampton","year":"2015","unstructured":"Hampton MM (2015) Congenital toxoplasmosis: a review. Neonatal Netw 34(5):274\u2013278. https:\/\/doi.org\/10.1891\/0730-0832.34.5.274","journal-title":"Neonatal Netw"},{"issue":"11","key":"845_CR5","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1017\/S0950268812001392","volume":"140","author":"JP Dubey","year":"2012","unstructured":"Dubey JP, Tiao N, Gebreyes WA, Jones JL (2012) A review of toxoplasmosis in humans and animals in Ethiopia. Epidemiol Infect 140(11):1935\u20131938. https:\/\/doi.org\/10.1017\/S0950268812001392","journal-title":"Epidemiol Infect"},{"key":"845_CR6","doi-asserted-by":"crossref","unstructured":"McCabe RE (2001) Antitoxoplasma chemotherapy. Toxoplasmosis: a comprehensive clinical guide.:319\u2013\u200959","DOI":"10.1017\/CBO9780511527005.015"},{"key":"845_CR7","doi-asserted-by":"publisher","unstructured":"Montazeri M, Mehrzadi S, Sharif M, Sarvi S, Tanzifi A, Aghayan SA, Daryani A (2018) Drug resistance in Toxoplasma Gondii. Front Microbiol 9:2587. https:\/\/doi.org\/10.3389\/fmicb.2018.02587","DOI":"10.3389\/fmicb.2018.02587"},{"issue":"5","key":"845_CR8","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1097\/00006254-200105000-00025","volume":"56","author":"JL Jones","year":"2001","unstructured":"Jones JL, Lopez A, Wilson M, Schulkin J, Gibbs R (2001) Congenital toxoplasmosis: a review. Obstet Gynecol Surv 56(5):296\u2013305. https:\/\/doi.org\/10.1097\/00006254-200105000-00025","journal-title":"Obstet Gynecol Surv"},{"issue":"4","key":"845_CR9","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/cmr.00057-17","volume":"31","author":"IR Dunay","year":"2018","unstructured":"Dunay IR, Gajurel K, Dhakal R, Liesenfeld O, Montoya JG (2018) Treatment of toxoplasmosis: historical perspective, animal models, and current clinical practice. Clin Microbiol Rev 31(4):10\u2013128. https:\/\/doi.org\/10.1128\/cmr.00057-17","journal-title":"Clin Microbiol Rev"},{"key":"845_CR10","doi-asserted-by":"publisher","unstructured":"Marra CM (2018) Central nervous system infection with Toxoplasma Gondii. Handbook of clinical neurology. 152:117\u2013122. https:\/\/doi.org\/10.1016\/b978-0-444-63849-6.00009-8","DOI":"10.1016\/b978-0-444-63849-6.00009-8"},{"issue":"8","key":"845_CR11","doi-asserted-by":"publisher","first-page":"668","DOI":"10.2174\/1389557515666150709105129","volume":"16","author":"P Formoso","year":"2016","unstructured":"Formoso P, Muzzalupo R, Tavano L, De Filpo G, Pasquale Nicoletta F (2016) Nanotechnology for the environment and medicine. Mini Rev Med Chem 16(8):668\u2013675. https:\/\/doi.org\/10.2174\/1389557515666150709105129","journal-title":"Mini Rev Med Chem"},{"issue":"12","key":"845_CR12","doi-asserted-by":"publisher","first-page":"2538","DOI":"10.3390\/nano10122538","volume":"10","author":"AE Albalawi","year":"2020","unstructured":"Albalawi AE, Alanazi AD, Baharvand P, Sepahvand M, Mahmoudvand H (2020) High potency of organic and inorganic nanoparticles to treat cystic echinococcosis: an evidence-based review. Nanomaterials 10(12):2538. https:\/\/doi.org\/10.3390\/nano10122538","journal-title":"Nanomaterials"},{"issue":"1","key":"845_CR13","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1099\/jmm.0.001111","volume":"69","author":"A Keyhani","year":"2020","unstructured":"Keyhani A, Ziaali N, Shakibaie M, Kareshk AT, Shojaee S, Asadi-Shekaari M, Sepahvand M, Mahmoudvand H (2020) Biogenic selenium nanoparticles target chronic toxoplasmosis with minimal cytotoxicity in a mouse model. J Med Microbiol 69(1):104\u2013110. https:\/\/doi.org\/10.1099\/jmm.0.001111","journal-title":"J Med Microbiol"},{"issue":"16","key":"845_CR14","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.2174\/1568026615666150414142209","volume":"15","author":"S Marin","year":"2015","unstructured":"Marin S, Mihail Vlasceanu G, Elena Tiplea R, Raluca Bucur I, Lemnaru M, Minodora Marin M, Mihai Grumezescu A (2015) Applications and toxicity of silver nanoparticles: a recent review. Curr Top Med Chem 15(16):1596\u20131604. https:\/\/doi.org\/10.2174\/1568026615666150414142209","journal-title":"Curr Top Med Chem"},{"key":"845_CR15","doi-asserted-by":"publisher","first-page":"128580","DOI":"10.1016\/j.chemosphere.2020.128580","volume":"264","author":"A Saravanan","year":"2021","unstructured":"Saravanan A, Kumar PS, Karishma S, Vo DV, Jeevanantham S, Yaashikaa PR, George CS (2021) A review on biosynthesis of metal nanoparticles and its environmental applications. Chemosphere 264:128580. https:\/\/doi.org\/10.1016\/j.chemosphere.2020.128580","journal-title":"Chemosphere"},{"issue":"4","key":"845_CR16","doi-asserted-by":"publisher","first-page":"742","DOI":"10.3390\/polym14040742","volume":"14","author":"MA Huq","year":"2022","unstructured":"Huq MA, Ashrafudoulla M, Rahman MM, Balusamy SR, Akter S (2022) Green synthesis and potential antibacterial applications of bioactive silver nanoparticles: a review. Polymers 14(4):742. https:\/\/doi.org\/10.3390\/polym14040742","journal-title":"Polymers"},{"key":"845_CR17","doi-asserted-by":"publisher","first-page":"623947","DOI":"10.3389\/fmicb.2020.623947","volume":"11","author":"IN Costa","year":"2021","unstructured":"Costa IN, Ribeiro M, Silva Franco P, da Silva RJ, de Ara\u00fajo TE, Mili\u00e1n IC, Luz LC, Guirelli PM, Nakazato G, Mineo JR, Mineo TW (2021) Biogenic silver nanoparticles can control toxoplasma gondii infection in both human trophoblast cells and villous explants. Front Microbiol 11:623947. https:\/\/doi.org\/10.3389\/fmicb.2020.623947","journal-title":"Front Microbiol"},{"issue":"5","key":"845_CR18","doi-asserted-by":"publisher","first-page":"104971","DOI":"10.1016\/j.micinf.2022.104971","volume":"24","author":"RA da Silva Sanfelice","year":"2022","unstructured":"da Silva Sanfelice RA, Silva TF, Tomiotto-Pellissier F, da Silva Bortoleti BT, Lazarin-Bid\u00f3ia D, Scandorieiro S, Nakazato G, de Barros LD, Garcia JL, Verri WA, Conchon-Costa I (2022) Biogenic silver nanoparticles reduce Toxoplasma Gondii infection and proliferation in RAW 264.7 macrophages by inducing tumor necrosis factor-alpha and reactive oxygen species production in the cells. Microbes Infect 24(5):104971. https:\/\/doi.org\/10.1016\/j.micinf.2022.104971","journal-title":"Microbes Infect"},{"issue":"11","key":"845_CR19","doi-asserted-by":"publisher","first-page":"6454","DOI":"10.1016\/j.sjbs.2021.07.007","volume":"28","author":"M Saadatmand","year":"2021","unstructured":"Saadatmand M, Al-Awsi GR, Alanazi AD, Sepahvand A, Shakibaie M, Shojaee S, Mohammadi R, Mahmoudvand H (2021) Green synthesis of zinc nanoparticles using Lavandula angustifolia Vera. Extract by microwave method and its prophylactic effects on Toxoplasma Gondii infection. Saudi J Biol Sci 28(11):6454\u20136460. https:\/\/doi.org\/10.1016\/j.sjbs.2021.07.007","journal-title":"Saudi J Biol Sci"},{"key":"845_CR20","doi-asserted-by":"publisher","unstructured":"Mahmoudvand H, Kheirandish F, Ghasemi Kia M, Tavakoli Kareshk A, Yarahmadi M (2016) Chemical composition, protoscolicidal effects and acute toxicity of Pistacia atlantica Desf. Fruit extract. Nat Prod Res 30(10):1208\u20131211. https:\/\/doi.org\/10.1080\/14786419.2015.1046868","DOI":"10.1080\/14786419.2015.1046868"},{"key":"845_CR21","doi-asserted-by":"publisher","first-page":"111257","DOI":"10.1016\/j.biopha.2021.111257","volume":"136","author":"F Ezzatkhah","year":"2021","unstructured":"Ezzatkhah F, Khalaf AK, Mahmoudvand H (2021) Copper nanoparticles: biosynthesis, characterization, and protoscolicidal effects alone and combined with albendazole against hydatid cyst protoscoleces. Biomed Pharmacother 136:111257. https:\/\/doi.org\/10.1016\/j.biopha.2021.111257","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"845_CR22","doi-asserted-by":"publisher","first-page":"891","DOI":"10.3390\/nano11040891","volume":"11","author":"AE Albalawi","year":"2021","unstructured":"Albalawi AE, Abdel-Shafy S, Khudair Khalaf A, Alanazi AD, Baharvand P, Ebrahimi K, Mahmoudvand H (2021) Therapeutic potential of green synthesized copper nanoparticles alone or combined with meglumine antimoniate (glucantime\u00ae) in cutaneous leishmaniasis. Nanomaterials 11(4):891. https:\/\/doi.org\/10.3390\/nano11040891","journal-title":"Nanomaterials"},{"key":"845_CR23","doi-asserted-by":"publisher","first-page":"111566","DOI":"10.1016\/j.biopha.2021.111566","volume":"139","author":"AE Albalawi","year":"2021","unstructured":"Albalawi AE, Khalaf AK, Alyousif MS, Alanazi AD, Baharvand P, Shakibaie M, Mahmoudvand H (2021) Fe3O4@ piroctone olamine magnetic nanoparticles: synthesize and therapeutic potential in cutaneous leishmaniasis. Biomed Pharmacother 139:111566. https:\/\/doi.org\/10.1016\/j.biopha.2021.111566","journal-title":"Biomed Pharmacother"},{"issue":"7","key":"845_CR24","doi-asserted-by":"publisher","first-page":"355","DOI":"10.3390\/tropicalmed8070355","volume":"8","author":"AD Alanazi","year":"2023","unstructured":"Alanazi AD, Majeed QA, Alnomasy SF, Almohammed HI (2023) Potent in Vitro and in vivo effects of Stachys Lavandulifolia Methanolic Extract against Toxoplasma gondii infection. Trop Med Infect Disease 8(7):355. https:\/\/doi.org\/10.3390\/tropicalmed8070355","journal-title":"Trop Med Infect Disease"},{"issue":"80","key":"845_CR25","doi-asserted-by":"publisher","first-page":"830","DOI":"10.4103\/pm.pm_53_22","volume":"18","author":"HI Almohammed","year":"2022","unstructured":"Almohammed HI, Alanazi AD (2022) In vitro\/in vivo Assessment and Cellular mechanisms of Astragalus Spinosus Extract against Leishmania major. Pharmacognosy Magazine 18(80):830\u2013835. https:\/\/doi.org\/10.4103\/pm.pm_53_22","journal-title":"Pharmacognosy Magazine"},{"issue":"4","key":"845_CR26","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1007\/s11686-021-00421-4","volume":"66","author":"AE Albalawi","year":"2021","unstructured":"Albalawi AE, Alanazi AD, Alyousif MS, Sepahvand A, Ebrahimi K, Niazi M, Mahmoudvand H (2021) The high potency of green synthesized copper nanoparticles to prevent the Toxoplasma gondii infection in mice. Acta Parasitol 66(4):1472\u20131479. https:\/\/doi.org\/10.1007\/s11686-021-00421-4","journal-title":"Acta Parasitol"},{"issue":"4","key":"845_CR27","doi-asserted-by":"publisher","first-page":"819","DOI":"10.3390\/molecules26040819","volume":"26","author":"RM Shaapan","year":"2021","unstructured":"Shaapan RM, Al-Abodi HR, Alanazi AD, Abdel-Shafy S, Rashidipour M, Shater AF, Mahmoudvand H (2021) Myrtus communis essential oil; anti-parasitic effects and induction of the innate immune system in mice with Toxoplasma Gondii infection. Molecules 26(4):819. https:\/\/doi.org\/10.3390\/molecules26040819","journal-title":"Molecules"},{"key":"845_CR28","doi-asserted-by":"publisher","first-page":"900046","DOI":"10.3389\/fcimb.2022.900046","volume":"12","author":"AD Alanazi","year":"2022","unstructured":"Alanazi AD, Almohammed HI (2022) Therapeutic potential and safety of the Cinnamomum zeylanicum Methanolic Extract against Chronic Toxoplasma Gondii Infection in mice. Front Cell Infect Microbiol 12:900046. https:\/\/doi.org\/10.3389\/fcimb.2022.900046","journal-title":"Front Cell Infect Microbiol"},{"key":"845_CR29","doi-asserted-by":"publisher","unstructured":"Alday PH, Doggett JS (2017) Drugs in development for toxoplasmosis: advances, challenges, and current status. Drug Des Devel Ther 273\u2013293. https:\/\/doi.org\/10.2147\/dddt.s60973","DOI":"10.2147\/dddt.s60973"},{"issue":"4","key":"845_CR30","doi-asserted-by":"publisher","first-page":"e104248","DOI":"10.5812\/jamm.104248","volume":"7","author":"A KarimiPourSaryazdi","year":"2019","unstructured":"KarimiPourSaryazdi A, Tavakoli P, Barati M, Ghaffarifar F, Ghaffari D (2019) Anti-toxoplasma effects of Silver nanoparticles based on Ginger Extract: an in Vitro Study. J Arch Mil Med 7(4):e104248. https:\/\/doi.org\/10.5812\/jamm.104248","journal-title":"J Arch Mil Med"},{"key":"845_CR31","doi-asserted-by":"publisher","unstructured":"Hematizadeh A, Ebrahimzadeh MA, Sarvi S, Sadeghi M, Daryani A, Gholami S, Nayeri T, Hosseini SA (2023) In Vitro and in vivo anti-parasitic activity of Sambucus ebulus and Feijoa sellowiana extracts silver nanoparticles on Toxoplasma Gondii tachyzoites. Acta Parasitol 1\u20139. https:\/\/doi.org\/10.1007\/s11686-023-00689-8","DOI":"10.1007\/s11686-023-00689-8"},{"issue":"Academic issue","key":"845_CR32","doi-asserted-by":"publisher","first-page":"186","DOI":"10.21608\/bmfj.2021.58655.1372","volume":"38","author":"M Saleh","year":"2021","unstructured":"Saleh M, Nagaty I, Zalat R, Yaseen D, Abdelhameed R, Kishik S (2021) Assessment of Nitazoxanide loaded on silver nanoparticles efficacy on treatment of Murine Model of Chronic Toxoplasmosis. Benha Med J 38(Academic issue):186\u2013199. https:\/\/doi.org\/10.21608\/bmfj.2021.58655.1372","journal-title":"Benha Med J"},{"key":"845_CR33","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.exppara.2014.05.005","volume":"143","author":"MR Gaafar","year":"2014","unstructured":"Gaafar MR, Mady RF, Diab RG, Shalaby TI (2014) Chitosan and silver nanoparticles: promising anti-toxoplasma agents. Exp Parasitol 143:30\u201338. https:\/\/doi.org\/10.1016\/j.exppara.2014.05.005","journal-title":"Exp Parasitol"},{"issue":"5","key":"845_CR34","doi-asserted-by":"publisher","first-page":"BSR20190379","DOI":"10.1042\/BSR20190379","volume":"39","author":"RA Alajmi","year":"2019","unstructured":"Alajmi RA, Al-Megrin WA, Metwally D, Al-Subaie H, Altamrah N, Barakat AM, Abdel Moneim AE, Al-Otaibi TT, El-Khadragy M (2019) Anti-toxoplasma activity of silver nanoparticles green synthesized with Phoenix dactylifera and Ziziphus spina-christi extracts which inhibits inflammation through liver regulation of cytokines in Balb\/c mice. Biosci Rep 39(5):BSR20190379. https:\/\/doi.org\/10.1042\/BSR20190379","journal-title":"Biosci Rep"},{"key":"845_CR35","doi-asserted-by":"publisher","unstructured":"James SL (1995) Role of nitric oxide in parasitic infections. Microbiological reviews. 1995; 59(4), 533\u2013547. https:\/\/doi.org\/10.1128\/mr.59.4.533-547.1995","DOI":"10.1128\/mr.59.4.533-547.1995"},{"issue":"2","key":"845_CR36","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1006\/expr.1994.1022","volume":"78","author":"RT Gazzinelli","year":"1994","unstructured":"Gazzinelli RT, Brezin A, Li QI, Nussenblatt RB, Chan CC (1994) Toxoplasma Gondii: acquired ocular toxoplasmosis in the murine model, protective role of TNF-\u03b1 and IFN-\u03b3. Exp Parasitol 78(2):217\u2013229. https:\/\/doi.org\/10.1006\/expr.1994.1022","journal-title":"Exp Parasitol"},{"issue":"4","key":"845_CR37","doi-asserted-by":"publisher","first-page":"521","DOI":"10.18502\/ijpa.v15i4.4857","volume":"15","author":"ZH Nazarlu","year":"2020","unstructured":"Nazarlu ZH, Matini M, Bahmanzadeh M, Foroughi-Parvar F (2020) Toxoplasma Gondii: a possible inducer of oxidative stress in reproductive system of male rats. Iran J Parasitol 15(4):521. https:\/\/doi.org\/10.18502\/ijpa.v15i4.4857","journal-title":"Iran J Parasitol"},{"issue":"11","key":"845_CR38","doi-asserted-by":"publisher","first-page":"5705","DOI":"10.3390\/ijms22115705","volume":"22","author":"K Szewczyk-Golec","year":"2021","unstructured":"Szewczyk-Golec K, Paw\u0142owska M, Weso\u0142owski R, Wr\u00f3blewski M, Mila-Kierzenkowska C (2021) Oxidative stress as a possible target in the treatment of Toxoplasmosis: perspectives and ambiguities. Int J Mol Sci 22(11):5705. https:\/\/doi.org\/10.3390\/ijms22115705","journal-title":"Int J Mol Sci"},{"issue":"3","key":"845_CR39","doi-asserted-by":"publisher","first-page":"199","DOI":"10.3347\/kjp.2012.50.3.199","volume":"50","author":"M Selseleh","year":"2012","unstructured":"Selseleh M, Modarressi MH, Mohebali M, Shojaee S, Eshragian MR, Selseleh M, Azizi E, Keshavarz H (2012) Real-time RT-PCR on SAG1 and BAG1 gene expression during stage conversion in immunosuppressed mice infected with Toxoplasma Gondii Tehran strain. Korean J Parasitol 50(3):199\u2013205. https:\/\/doi.org\/10.3347\/kjp.2012.50.3.199","journal-title":"Korean J Parasitol"}],"container-title":["Acta Parasitologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11686-024-00845-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11686-024-00845-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11686-024-00845-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T08:19:31Z","timestamp":1718612371000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11686-024-00845-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,18]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["845"],"URL":"https:\/\/doi.org\/10.1007\/s11686-024-00845-8","relation":{},"ISSN":["1230-2821","1896-1851"],"issn-type":[{"value":"1230-2821","type":"print"},{"value":"1896-1851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,18]]},"assertion":[{"value":"11 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}